DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care

NRx Pharmaceuticals, Inc. NASDAQ: NRXP

NRx Pharmaceuticals, Inc. NASDAQ: NRXP Financing

NASDAQ: NRXP $NRXP

❮

❯

Read Full Article »DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care